Delay in diagnosis is associated with decreased treatment effectiveness in children with rumination syndrome

Abstract

AbstractObjectivesRumination syndrome (RS) is challenging to diagnose, which can lead to diagnostic delays. Our objective was to evaluate the length of time from RS symptom onset to diagnosis in patients referred to our institution and to examine whether this duration predicts treatment outcomes.MethodsWe conducted a review of patients with RS evaluated at our institution. Data were collected from chart review and patient/family reported questionnaires. We evaluated the time from symptom onset to diagnosis over time and whether it was associated with symptom resolution.ResultsWe included 247 patients with RS (60% female, median age of 14 years, interquartile range [IQR]: 9–16 years). The median age at symptom onset was 11 years (IQR: 5–14 years) and median age at diagnosis was 13 years (IQR: 9–15 years) for a median duration of 1 year (IQR: 0–3 years) between symptom onset and diagnosis. Length of time between symptom onset and diagnosis did not change significantly at our institution from 2016 to 2022. Among the 164 children with outcome data, 47 (29%) met criteria for symptom resolution after treatment. A longer time to diagnosis was associated with a lower likelihood of symptom resolution after treatment (p = 0.01).ConclusionIn our experience, the time to RS diagnosis after symptom onset is shorter than previously described. A longer delay in diagnosis is associated with lower likelihood of symptom resolution after treatment, emphasizing the importance of a prompt recognition of rumination symptoms and a timely diagnosis.